Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04494737 · ClinicalTrials.gov registry record · NA
Wellbeing, Stress Reduction and Social Cognition
A NA study of Cognitive Function 1, Social, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04494737: Completed NA study of Cognitive Function 1, Social, sponsored by Massachusetts General Hospital.
NCT04494737 is a NA study of Cognitive Function 1, Social that has completed, run by Massachusetts General Hospital. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04494737, a NA study of Cognitive Function 1, Social, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
There are many ways to improve wellbeing. This study will compare two 8-week wellbeing training programs. In addition to looking at how well the programs reduce stress and enhance wellbeing, the investigators will also ask questions about how these programs influence cognition and decision making.
Primary Outcome
The name of the measurement is neural functioning during moral decision-making. To assess neural functioning, participants will undergo a functional MRI scan while they perform a moral judgment task. The task that involves moral (n=18) and non-moral (n=18) dilemma vignettes. These dilemmas have been validated and will be presented as text in an event related design. The participant specific task-related brain activity will be generated by contrasting brain activity between moral and non-moral di
Conditions Studied
Interventions
- BEHAVIORAL Active Comparator: Program 1
- BEHAVIORAL Active Comparator: Program 2
Study Locations (1)
Massachusetts
- MGH - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-01-05 |
| Est. Completion | 2021-08-30 |
| Phase | NA |
What the finished NCT04494737 record still lists
NCT04494737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cognitive Function 1, Social appearing as the primary indexed condition, and to 2 interventions - of which Active Comparator: Program 1 is the first listed.
NCT04494737 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04494737 about?
NCT04494737 is a clinical study titled "Wellbeing, Stress Reduction and Social Cognition". There are many ways to improve wellbeing. This study will compare two 8-week wellbeing training programs. In addition to looking at how well the programs reduce stress and enhance wellbeing, the investigators will also ask questions about how these programs influence cognition and decision making.
What is the current status of trial NCT04494737?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-01-05. Estimated completion is 2021-08-30.
What conditions does trial NCT04494737 study?
This clinical trial studies the following conditions: Cognitive Function 1, Social.
What interventions are being tested in trial NCT04494737?
The interventions under investigation include: Active Comparator: Program 1 (BEHAVIORAL), Active Comparator: Program 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT04494737?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04494737 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04494737's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI